Skip to main content

Leonite Capital LLC's Form 4 filing

Pasithea Therapeutics Corp. (KTTA) · filed Aug 26, 2022

Accession no.
0001209191-22-047714
Filed
Aug 26, 2022, 4:30 PM ET
Trade date
Aug 19, 2022
Filing delay
7 daysLate
Rule 10b5-1 plan
Not on the form (before 2023)

This filing lists 1 non-derivative transaction and 0 derivative transactions. Open-market purchases total $70.9K. It was filed 7 days after the trade, past the 2-business-day deadline.

Reporting owners

A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.

Reporting owners on this filing
OwnerRelationship to the company
Leonite Capital LLCCIK 0001824520Other: Member of 10% owner group
Geller AviCIK 0001883076Other: Member of 10% owner group
Leonite Fund I, LPCIK 0001944053Other: Member of 10% owner group

Non-derivative securities (Table I)

Acquisitions and disposals of common stock and similar shares, one row per line on the filing.

Non-derivative transactions
Trade dateSecurityTransactionSharesPriceValueShares afterOwnershipFlags
Aug 19, 2022Common StockPPurchaseAcquired+54,644$1.30+$70,938.8454,644Indirect

Footnotes

Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.

Read the original on SEC EDGAR (opens in a new tab)